Key terms

About WST

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest WST news

Today 5:09am ET West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating Yesterday 7:52am ET West Pharmaceutical Services Unveils Latest Financial Results Yesterday 6:22am ET West Pharmaceutical raises FY24 adjusted EPS $7.63-$7.88 from $7.50-$7.75 Yesterday 6:20am ET West Pharmaceutical reports Q1 adjusted EPS $1.56, consensus $1.26 Apr 18 3:06am ET Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry Feb 22 2:05am ET Buy Rating Affirmed for West Pharmaceutical Services on Robust Market Position and Growth Prospects Feb 16 8:40am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO), Ultragenyx Pharmaceutical (RARE) and West Pharmaceutical Services (WST) Feb 16 7:26am ET West Pharmaceutical price target lowered to $400 from $430 at BofA Feb 15 10:00am ET West Pharmaceutical falls -18.8% Feb 15 8:02am ET West Pharmaceutical Services Reports Key Financial Results Feb 15 6:07am ET West Pharmaceutical sees FY24 adjusted EPS $7.50-$7.75, consensus $8.76 Feb 15 6:03am ET West Pharmaceutical reports Q4 EPS $1.83, consensus $1.78 Feb 07 5:06am ET West Pharmaceutical upgraded to Buy from Hold at Jefferies Feb 06 5:52am ET WST Stock: Is There More Steam Left in the Rally? Feb 06 1:51am ET SPY ETF Update, 2/6/2024 Feb 01 11:48pm ET SPY ETF Update, 2/2/2024 Jan 31 1:34am ET SPY ETF Update, 1/31/2024

No recent press releases are available for WST

WST Financials

1-year income & revenue

Key terms

WST Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

WST Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms